Acquisition of MDMA self-administration: Pharmacokinetic factors and MDMA-induced serotonin release

Addiction Biology

Volumn 19, Issue 5, 2014, Pages 874-884

  Bradbury, Sarah ^a   Bird, Judith ^a   Colussi Mas, Joyce ^a   Mueller, Melanie ^b   Ricaurte, George ^b   Schenk, Susan ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; MDMA; microdialysis; pharmacokinetics; self administration; serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5,7 DIHYDROXYTRYPTAMINE; DOPAMINE; SEROTONIN; COCAINE; DOPAMINE UPTAKE INHIBITOR; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; IN VIVO STUDY; LATENT PERIOD; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SYNAPSE; TISSUE LEVEL; ANIMAL; AREA UNDER THE CURVE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; AREA UNDER CURVE; COCAINE; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; INFUSIONS, INTRAVENOUS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN; SEROTONIN AGENTS;

EID: 84906314871     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12069     Document Type: Article

References (51)

1. Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB, (2005) N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology 30: 550-560.
2. Baumann MH, Clark RD, Franken FH, Rutter JJ, Rothman RB, (2008a) Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152: 773-784.
3. Baumann MH, Clark RD, Rothman RB, (2008b) Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90: 208-217.
4. Bird J, Schenk S, (2012) Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration. Addict Biol. doi: 10.1111/j.1369-1600.2012.00477.x.
5. Brennan KA, Carati C, Lea RA, Fitzmaurice PS, Schenk S, (2009) Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behav Pharmacol 20: 688-694.
6. Carroll ME, Lac ST, (1997) Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology (Berl) 129: 206-214.
7. Carroll ME, Lac ST, Asencio M, Kragh R, (1990a) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35: 237-244.
8. Carroll ME, Lac ST, Asencio M, Kragh R, (1990b) Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology (Berl) 100: 293-300.
9. Colussi-Mas J, Wise RJ, Howard A, Schenk S, (2010) Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine. Int J Neuropsychopharmacol 13: 1315-1327.
10. Daniela E, Brennan K, Gittings D, Hely L, Schenk S, (2004) Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol Biochem Behav 77: 745-750.
11. Degenhardt L, Bruno R, Topp L, (2010) Is ecstasy a drug of dependence? Drug Alcohol Depend 107: 1-10.
12. Do J, Schenk S, (2013) Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain. Addict Biol 18: 441-447.
13. Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G, (2002) 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl) 161: 356-364.
14. Fletcher PJ, Korth KM, Chambers JW, (1999) Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions. Psychopharmacology (Berl) 146: 185-193.
15. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI, (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol Rev 55: 463-508.
16. Hooks MS, Colvin AC, Juncos JL, Justice JB Jr, (1992) Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res 587: 306-312.
17. Kalivas PW, Duffy P, White SR, (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18: 469-479.
18. Kurling S, Kankaanpää A, Seppälä T, (2008) Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats. Behav Brain Res 189: 191-201.
19. Leccese AP, Lyness WH, (1984) The effects of putative 5-hydroxytryptamine receptor active agents on d-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions. Brain Res 303: 153-162.
20. Lyness WH, Friedle NM, Moore KE, (1980) Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12: 937-941.
21. Marinelli M, White FJ, (2000) Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20: 6676-6685.
22. Mueller M, Peters FT, Ricaurte GA, Maurer HH, (2007) Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma. J Chromatogr B Analyt Technol Biomed Life Sci 855: 262-270.
23. Mueller M, Yuan J, Maldonado Adrian C, McCann UD, Ricaurte GA, (2011) Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity. Synapse 65: 983-990.
24. Nelson AM, Larson GA, Zahniser NR, (2009) Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number. J Pharmacol Exp Ther 331: 985-997.
25. O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI, (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30: 1312-1323.
26. Paxinos G, Watson C, (2005) The Rat Brain in Stereotaxic Coordinates, 5th edn San Diego, CA: Elsevier: Academic Press.
27. Pelloux Y, Dilleen R, Economidou D, Theobald D, Everitt BJ, (2012) Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats. Neuropsychopharmacology 37: 2505-2514.
28. Piazza PV, Rougé-Pont F, Deminière JM, Kharoubi M, Le Moal M, Simon H, (1991) Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res 567: 169-174.
29. Porrino LJ, Ritz MC, Goodman NL, Sharpe LG, Kuhar MJ, Goldberg SR, (1989) Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45: 1529-1535.
30. Ranaldi R, Pocock D, Zereik R, Wise RA, (1999) Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous d-amphetamine self-administration. J Neurosci 19: 4102-4109.
31. Ratzenboeck E, Saria A, Kriechbaum N, Zernig G, (2001) Reinforcing effects of MDMA ('ecstasy') in drug-naive and cocaine-trained rats. Pharmacology 62: 138-144.
32. Reveron ME, Maier EY, Duvauchelle CL, (2010) Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ('Ecstasy') self-administration. Behav Brain Res 207: 500-507.
33. Roberts DC, Loh EA, Baker GB, Vickers G, (1994) Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Behav 49: 177-182.
34. Schenk S, (2009) MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 60: 130-136.
35. Schenk S, (2011) MDMA ('ecstasy') abuse as an example of dopamine neuroplasticity. Neurosci Biobehav Rev 35: 1203-1218.
36. Schenk S, Gittings D, Colussi-Mas J, (2011) Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. Br J Pharmacol 162: 1770-1778.
37. Schenk S, Gittings D, Johnstone M, Daniela E, (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 169: 21-27.
38. Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC, (2007) MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Eur J Neurosci 26: 3229-3236.
39. Schenk S, Horger BA, Peltier R, Shelton K, (1991) Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res 543: 227-235.
40. Schenk S, Partridge B, (2000) Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats. Pharmacol Biochem Behav 66: 765-770.
41. Schenk S, Valadez A, McNamara C, House DT, Higley D, Bankson MG, et al. (1993) Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology (Berl) 111: 332-338.
42. Shankaran M, Gudelsky GA, (1999) A neurotoxic regimen of MDMA suppresses behavioural, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology (Berl) 147: 66-72.
43. Solowij N, Hall W, Lee N, (1992) Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. Br J Addict 87: 1161-1172.
44. Suto N, Ecke LE, You ZB, Wise RA, (2010) Extracellular fluctuations of dopamine and glutamate in the nucleus accumbens core and shell associated with lever-pressing during cocaine self-administration, extinction, and yoked cocaine administration. Psychopharmacology (Berl) 211: 267-275.
45. Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A, (2005) Mental disorders in currentand former heavy ecstasy (MDMA) users. Addiction 100: 1310-1319.
46. United Nations World Drug Report (2012) World Drug Report 2012. Vienna: United Nations Publication.
47. Wang Z, Woolverton WL, (2007) Estimating the relative reinforcing strength of (+/-)- 3, 4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine. Psychopharmacology (Berl) 189: 483-488.
48. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL, (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313: 848-854.
49. Wee S, Woolverton WL, (2006) Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys. Pharmacol Biochem Behav 84: 337-343.
50. Weiss F, Hurd YL, Ungerstedt U, Markou A, Plotsky PM, Koob GF, (1992) Neurochemical correlates of cocaine and ethanol self-administration. Ann N Y Acad Sci 28: 220-241.
51. Wise RA, (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51: 13-22.